Disclosure statement
Louise Roulin received lecture fees from Janssen. Alizée Maarek received lecture fees from Takeda and Sandoz. Corinne Haioun received consulting or lecture fees from Roche, Celgene, Janssen, Gilead, Takeda, Novartis, Amgen as well as travel accommodations from Roche, Celgene, Amgen. Karim Belhadj received consulting or lecture fees from Takeda, Amgen, Celgene, Janssen. The remaining authors declare no competing financial interests.
Table 1b.